Mehrle et al. reported that the up-regulation or silencing of SLAMF1 in human lymphocytes was accompanied by increased or decreased cytotoxic activity respectively, and suggested the implication of SLAMF1 in cytotoxicity against human colon cancer. Here, SLAMF1 is linked to colonic neoplasm.